OCULAR VASCULAR DISORDER side effect
What is OCULAR VASCULAR DISORDER ?Drugs associated with OCULAR VASCULAR DISORDER
ALDURAZYME AVASTIN AVONEX BEXTRA CELEBREX CHANTIX CIALIS HUMIRA KENACORT LYRICA NASONEX NUTROPIN SUDAFED TAMOXIFEN VIAGRA VISUDYNE XALATANOCULAR VASCULAR DISORDER : Humira Side Effects Report #5667807-4
Consumer or non-health professional from UNITED STATES reported HUMIRA problem on Feb 04, 2008. Male patient, weighting 240.3 lb, was diagnosed with rheumatoid arthritis, blood triglycerides increased, diabetes mellitus, hypertension, glaucoma and was treated with HUMIRA. After drug was administered, patient experienced the following problems/side effects: ocular vascular disorder, vision blurred, . HUMIRA dosage: unknown. During the same period patient was treated with FENOFIBRATE, GLIBENCLAMIDE, METFORMIN, LISINOPRIL, HYDROXYCHLOROQUINE PHOSPHATE, TIMOLOL EYE DROPS. Patient recovered.
OCULAR VASCULAR DISORDER : Kenacort Side Effects Report #5674176-2
KENACORT problem was reported by a Health Professional from TURKEY on Mar 17, 2008. Female patient, 19 years of age, was diagnosed with chalazion and was treated with KENACORT. After drug was administered, patient experienced the following problems/side effects: ocular vascular disorder, optic atrophy, retinal haemorrhage, retinal vascular occlusion, . KENACORT dosage: 1 FORM= 40MG/ML.. Patient recovered.
OCULAR VASCULAR DISORDER : Kenacort Side Effects Report #5680411-7
Health Professional from TURKEY reported KENACORT problem on Mar 19, 2008. Female patient, 19 years of age, was diagnosed with chalazion and was treated with KENACORT. After drug was administered, patient experienced the following problems/side effects: ocular vascular disorder, optic atrophy, retinal haemorrhage, retinal vascular occlusion, . KENACORT dosage: 1 FORM= 40MG/ML.. Patient recovered.
OCULAR VASCULAR DISORDER : Avastin Side Effects Report #5532270-0
AVASTIN problem was reported by a Consumer or non-health professional from UNITED STATES on Nov 27, 2007. Female patient was treated with AVASTIN. After drug was administered, patient experienced the following problems/side effects: ocular vascular disorder, retinal haemorrhage, uveitis, . AVASTIN dosage: 1.25 MG, Q2M. During the same period patient was treated with VIGAMOX, LIDOCAINE. Patient recovered.
OCULAR VASCULAR DISORDER : Nutropin Side Effects Report #5545723-6
Consumer or non-health professional from UNITED STATES reported NUTROPIN problem on Dec 06, 2007. Male patient was diagnosed with growth retardation and was treated with NUTROPIN. After drug was administered, patient experienced the following problems/side effects: ocular vascular disorder, . NUTROPIN dosage: unknown. Patient recovered.
OCULAR VASCULAR DISORDER : Avastin Side Effects Report #5508336-8
AVASTIN problem was reported by a Consumer or non-health professional from UNITED STATES on Oct 25, 2007. Female patient was treated with AVASTIN. After drug was administered, patient experienced the following problems/side effects: ocular vascular disorder, retinal haemorrhage, uveitis, . AVASTIN dosage: 1.25 MG, Q2M. During the same period patient was treated with VIGAMOX, LIDOCAINE. Patient recovered.
OCULAR VASCULAR DISORDER : Avonex Side Effects Report #5494228-X
Consumer or non-health professional from UNITED STATES reported AVONEX problem on Oct 12, 2007. Female patient, 60 years of age, was diagnosed with multiple sclerosis and was treated with AVONEX. After drug was administered, patient experienced the following problems/side effects: ocular vascular disorder, . AVONEX dosage: unknown. Patient recovered.
OCULAR VASCULAR DISORDER : Nutropin Side Effects Report #5469991-4
NUTROPIN problem was reported by a Consumer or non-health professional from UNITED STATES on Sept 17, 2007. Male patient was diagnosed with growth retardation and was treated with NUTROPIN. After drug was administered, patient experienced the following problems/side effects: ocular vascular disorder, . NUTROPIN dosage: unknown. Patient recovered.
OCULAR VASCULAR DISORDER : Xalatan Side Effects Report #5657449-9
Consumer or non-health professional from UNITED STATES reported XALATAN problem on Feb 28, 2008. Female patient was diagnosed with glaucoma and was treated with XALATAN. After drug was administered, patient experienced the following problems/side effects: eye operation, ocular vascular disorder, vascular injury, visual acuity reduced, weight decreased, . XALATAN dosage: unknown. During the same period patient was treated with DILANTIN, PHENOBARBITAL. Patient recovered.
OCULAR VASCULAR DISORDER : Bextra Side Effects Report #5673795-7
BEXTRA problem was reported by a Consumer or non-health professional from UNITED STATES on Mar 12, 2008. Female patient, weighting 237.0 lb, was treated with BEXTRA. After drug was administered, patient experienced the following problems/side effects: cerebrovascular accident, ocular vascular disorder, . BEXTRA dosage: unknown. Patient was hospitalized. Patient recovered.
OCULAR VASCULAR DISORDER : Viagra Side Effects Report #5645654-7
Consumer or non-health professional from UNITED STATES reported VIAGRA problem on Feb 19, 2008. Male patient, weighting 185.0 lb, was diagnosed with erectile dysfunction and was treated with VIAGRA. After drug was administered, patient experienced the following problems/side effects: ocular vascular disorder, optic ischaemic neuropathy, . VIAGRA dosage: unknown. Patient recovered.
OCULAR VASCULAR DISORDER : Sudafed Side Effects Report #5591429-7
SUDAFED problem was reported by a Consumer or non-health professional from UNITED STATES on Jan 04, 2008. Male patient, weighting 160.0 lb, was diagnosed with sinus congestion and was treated with SUDAFED. After drug was administered, patient experienced the following problems/side effects: ocular vascular disorder, . SUDAFED dosage: unknown. Patient recovered.
OCULAR VASCULAR DISORDER : Viagra Side Effects Report #5599323-2
Consumer or non-health professional from UNITED STATES reported VIAGRA problem on Jan 15, 2008. Male patient, weighting 250.0 lb, was diagnosed with erectile dysfunction and was treated with VIAGRA. After drug was administered, patient experienced the following problems/side effects: ocular vascular disorder, optic ischaemic neuropathy, . VIAGRA dosage: unknown. Patient recovered.
OCULAR VASCULAR DISORDER : Viagra Side Effects Report #5600697-4
VIAGRA problem was reported by a Consumer or non-health professional from UNITED STATES on Jan 15, 2008. Male patient, weighting 192.9 lb, was treated with VIAGRA. After drug was administered, patient experienced the following problems/side effects: ocular vascular disorder, vision blurred, . VIAGRA dosage: unknown. During the same period patient was treated with HYDROCHLOROTHIAZIDE, LIPITOR, ACEON, ACETAMINOPHEN, ASPIRIN. Patient recovered.
OCULAR VASCULAR DISORDER : Tamoxifen Side Effects Report #5606801-6
Pharmacist from CANADA reported TAMOXIFEN CITRATE problem on Jan 22, 2008. Female patient was diagnosed with breast cancer and was treated with TAMOXIFEN CITRATE. After drug was administered, patient experienced the following problems/side effects: embolism, ocular vascular disorder, . TAMOXIFEN CITRATE dosage: unknown. Patient recovered.
OCULAR VASCULAR DISORDER : Cialis Side Effects Report #5609342-5
CIALIS problem was reported by a Physician from CANADA on Jan 22, 2008. Male patient, 38 years of age, was diagnosed with erectile dysfunction and was treated with CIALIS. After drug was administered, patient experienced the following problems/side effects: ocular hyperaemia, ocular vascular disorder, visual field defect, . CIALIS dosage: 20 MG, AS NEEDED. Patient recovered.
OCULAR VASCULAR DISORDER : Cialis Side Effects Report #5545472-4
Physician from CANADA reported CIALIS problem on Nov 27, 2007. Male patient, 38 years of age, was treated with CIALIS. After drug was administered, patient experienced the following problems/side effects: ocular vascular disorder, visual field defect, . CIALIS dosage: 20 MG, AS NEEDED. Patient recovered.
OCULAR VASCULAR DISORDER : Visudyne Side Effects Report #5548200-1
VISUDYNE problem was reported by a Physician from JAPAN on Nov 21, 2007. Male patient, 62 years of age, weighting 154.4 lb, was treated with VISUDYNE. After drug was administered, patient experienced the following problems/side effects: choroidal infarction, ocular vascular disorder, . VISUDYNE dosage: unknown. Patient recovered.
OCULAR VASCULAR DISORDER : Chantix Side Effects Report #5580109-X
Consumer or non-health professional from UNITED STATES reported CHANTIX problem on Dec 27, 2007. Male patient, weighting 230.0 lb, was treated with CHANTIX. After drug was administered, patient experienced the following problems/side effects: eye disorder, ocular vascular disorder, visual acuity reduced, visual field defect, . CHANTIX dosage: 100 MG 2/DAY PO; 300 MG 2/DAY PO. Patient recovered.
OCULAR VASCULAR DISORDER : Avastin Side Effects Report #5475289-0
AVASTIN problem was reported by a Consumer or non-health professional from UNITED STATES on Sept 20, 2007. Female patient was treated with AVASTIN. After drug was administered, patient experienced the following problems/side effects: endophthalmitis, ocular vascular disorder, . AVASTIN dosage: unknown. Patient recovered.
OCULAR VASCULAR DISORDER : Avastin Side Effects Report #5484241-0
Consumer or non-health professional from UNITED STATES reported AVASTIN problem on Oct 02, 2007. Female patient was treated with AVASTIN. After drug was administered, patient experienced the following problems/side effects: endophthalmitis, ocular vascular disorder, . AVASTIN dosage: 1.25 MG, UNK. Patient recovered.
OCULAR VASCULAR DISORDER : Avastin Side Effects Report #5468752-X
AVASTIN problem was reported by a Consumer or non-health professional from UNITED STATES on Sept 14, 2007. Female patient was treated with AVASTIN. After drug was administered, patient experienced the following problems/side effects: endophthalmitis, ocular vascular disorder, . AVASTIN dosage: unknown. Patient recovered.
OCULAR VASCULAR DISORDER : Lyrica Side Effects Report #5468850-0
Consumer or non-health professional from UNITED STATES reported LYRICA problem on Sept 14, 2007. Male patient, weighting 304.9 lb, was diagnosed with peroneal muscular atrophy and was treated with LYRICA. After drug was administered, patient experienced the following problems/side effects: intraocular pressure increased, ocular vascular disorder, . LYRICA dosage: unknown. During the same period patient was treated with ACYCLOVIR, LIPITOR. Patient recovered.
OCULAR VASCULAR DISORDER : Celebrex Side Effects Report #5426382-X
CELEBREX problem was reported by a Consumer or non-health professional from UNITED STATES on Aug 15, 2007. Female patient, weighting 345.0 lb, was diagnosed with arthritis and was treated with CELEBREX. After drug was administered, patient experienced the following problems/side effects: cardiovascular disorder, ocular vascular disorder, . CELEBREX dosage: unknown. Patient recovered.
OCULAR VASCULAR DISORDER : Nasonex Side Effects Report #5444066-9
Consumer or non-health professional from UNITED STATES reported NASONEX problem on Aug 28, 2007. Female patient was treated with NASONEX. After drug was administered, patient experienced the following problems/side effects: eye haemorrhage, ocular vascular disorder, vitreous floaters, . NASONEX dosage: unknown. During the same period patient was treated with SINGULAIR, COUMADIN, DIGITEK, FLONASE, SPIRIVA. Patient recovered.
OCULAR VASCULAR DISORDER : Aldurazyme Side Effects Report #5390979-6
ALDURAZYME problem was reported by a Physician from UNITED STATES on Sept 27, 2005. Male patient, 31 years of age, weighting 122.8 lb, was diagnosed with mucopolysaccharidosis i and was treated with ALDURAZYME. After drug was administered, patient experienced the following problems/side effects: ocular vascular disorder, sialoadenitis, vascular occlusion, . ALDURAZYME dosage: 34.8 MG QWK IV. Patient was hospitalized. Patient recovered.
OCULAR VASCULAR DISORDER : Aldurazyme Side Effects Report #5390981-4
Physician from UNITED STATES reported ALDURAZYME problem on Sept 16, 2005. Male patient, 31 years of age, weighting 122.8 lb, was diagnosed with mucopolysaccharidosis i and was treated with ALDURAZYME. After drug was administered, patient experienced the following problems/side effects: ocular vascular disorder, sialoadenitis, vascular occlusion, . ALDURAZYME dosage: 34.8 MG QWK IV. Patient was hospitalized. Patient recovered.
OCULAR VASCULAR DISORDER : Aldurazyme Side Effects Report #5390979-6
ALDURAZYME problem was reported by a Physician from UNITED STATES on Sept 27, 2005. Male patient, 31 years of age, weighting 122.8 lb, was diagnosed with mucopolysaccharidosis i and was treated with ALDURAZYME. After drug was administered, patient experienced the following problems/side effects: ocular vascular disorder, sialoadenitis, vascular occlusion, . ALDURAZYME dosage: 34.8 MG QWK IV. Patient was hospitalized. Patient recovered.
OCULAR VASCULAR DISORDER : Aldurazyme Side Effects Report #5390981-4
Physician from UNITED STATES reported ALDURAZYME problem on Sept 16, 2005. Male patient, 31 years of age, weighting 122.8 lb, was diagnosed with mucopolysaccharidosis i and was treated with ALDURAZYME. After drug was administered, patient experienced the following problems/side effects: ocular vascular disorder, sialoadenitis, vascular occlusion, . ALDURAZYME dosage: 34.8 MG QWK IV. Patient was hospitalized. Patient recovered.
OCULAR VASCULAR DISORDER : Xalatan Side Effects Report #5639465-6
XALATAN problem was reported by a Consumer or non-health professional from UNITED STATES on Feb 19, 2008. Female patient was diagnosed with glaucoma and was treated with XALATAN. After drug was administered, patient experienced the following problems/side effects: device malfunction, eye operation, ocular vascular disorder, vascular injury, visual acuity reduced, weight decreased, . XALATAN dosage: unknown. During the same period patient was treated with DILANTIN, PHENOBARBITAL. Patient recovered.
OCULAR VASCULAR DISORDER : Celebrex Side Effects Report #5477507-1
Consumer or non-health professional from UNITED STATES reported CELEBREX problem on Sept 25, 2007. Female patient, weighting 130.1 lb, was diagnosed with myofascial pain syndrome, osteoarthritis and was treated with CELEBREX. After drug was administered, patient experienced the following problems/side effects: anxiety, neovascularisation, ocular vascular disorder, retinal haemorrhage, retinal vascular thrombosis, visual acuity reduced, . CELEBREX dosage: unknown. Patient was hospitalized and became disabled. Patient recovered.
OCULAR VASCULAR DISORDER : Celebrex Side Effects Report #5483189-5
CELEBREX problem was reported by a Consumer or non-health professional from UNITED STATES on Oct 01, 2007. Male patient, weighting 164.9 lb, was diagnosed with pain, rheumatoid arthritis and was treated with CELEBREX. After drug was administered, patient experienced the following problems/side effects: cerebrovascular accident, myocardial infarction, ocular vascular disorder, . CELEBREX dosage: unknown. Patient was hospitalized. Patient died on 10/18/2002.
OCULAR VASCULAR DISORDER : Bextra Side Effects Report #5441039-7
Consumer or non-health professional from UNITED STATES reported BEXTRA problem on Aug 20, 2007. Male patient, weighting 179.9 lb, was treated with BEXTRA. After drug was administered, patient experienced the following problems/side effects: cerebrovascular accident, myocardial infarction, ocular vascular disorder, visual acuity reduced, . BEXTRA dosage: unknown. Patient recovered.